Scientists are investigating a new approach to treating early-stage melanoma by directly applying anti-cancer drugs to the tumor site. Traditional methods of administering immunotherapy drugs cause whole-body side effects, but the new localized approach can reduce toxicity and potentially improve outcomes. By delivering drugs directly into the skin near the tumor, researchers have shown promising results in activating the immune system to fight cancer cells. This targeted treatment also helps generate memory T cells for long-lasting protection. These findings suggest a new treatment option for early-stage melanoma patients to reduce side effects, improve survival rates, and prevent cancer recurrence.
Source link
Finding a Better Way to Treat Melanoma
